நோர்வே தடுப்பூசி உயிரிழப்புகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Updated Jan 18, 2021 | 18:44 IST
The 29 cases were enough for Norway to revise its advisory, with the NMA now suggesting that, in the case of elderly and vulnerable patients, vaccine administration will be left to the doctor s discretion.
A woman receives the Pfizer-BioNTech vaccination against COVID-19 on 18 January, 2021.  |  Photo Credit: AP
Key Highlights
Norway has administered, at least, a single dose of the approved vaccine to over 42,000 people, the large majority of whom are elderly
It is expected that, as countries proceed with their immunisation programmes, more cases of rare reactions to vaccines will crop up
The other aspect to consider is that, given that the cases in Norway all involved frail and elderly patients, it is important to determine to what degree, if any at all, the vaccine may have contributed to the fatalities ....

Sigurd Hortemo , Steinar Madsen , Pfizer Inc , Norwegian Institute Of Public Health , Norwegian Medicines Agency , Photo Credit , Norwegian Institute , Public Health , Corona Virus , Covid 19 , Norway Vaccine Deaths , 29 Dead Norway , Pfizer Vaccine Side Effects , Pfizer Vaccine Safety , Covid Vaccine Safety , Covid Vaccine Safe , Norway Vaccine , ஸ்டீனர் பைத்தியம் , ஃபைசர் இன்க் , நோர்வே நிறுவனம் ஆஃப் பொது ஆரோக்கியம் , புகைப்படம் கடன் , நோர்வே நிறுவனம் , பொது ஆரோக்கியம் , கொரோனா வைரஸ் , நோர்வே தடுப்பூசி உயிரிழப்புகள் , ஃபைசர் தடுப்பூசி பக்க விளைவுகள் ,